Formulation and characterization of polyphenol-loaded lipid nanocapsules

被引:175
作者
Barras, A. [1 ]
Mezzetti, A. [2 ]
Richard, A. [1 ]
Lazzaroni, S. [2 ,3 ]
Roux, S. [1 ]
Melnyk, P. [1 ]
Betbeder, D. [4 ]
Monfilliette-Dupont, N. [1 ]
机构
[1] Univ Lille 1 & 2, Equipe Chim & MicroNanotechnol Visee Therapeut, CNRS, Inst Pasteur Lille,Inst Biol Lille,UMR 8161, F-59021 Lille, France
[2] Univ Sci & Technol Lille, LASIR, CNRS, UMR 8516, F-59655 Villeneuve Dascq, France
[3] Univ Pavia, Dept Organ Chem, I-27100 Pavia, Italy
[4] Univ Lille 2, Physiol Lab, EA 2689, Fac Med Pole Rech,IMPRT, F-59045 Lille, France
关键词
Polyphenol; Quercetin; (-)-Epigallocatechin gallate; Lipid nanocapsules; 3-HYDROXYFLAVONE; QUERCETIN; GALLATE; SPECTRA; AGENTS;
D O I
10.1016/j.ijpharm.2009.05.054
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The purpose of this study was to design and characterize two flavonoid-loaded lipid nanocapsules (LNC) by applying the phase inversion process, and to enhance their apparent solubility and/or the stability. The flavonoid-loaded LNC were characterized by particle size, encapsulation efficiency, drug leakage rates, stability and spectroscopic studies. It was observed that quercetin-loaded LNC30 (3%) and LNC60 (2%) carried a particle size of 30.3 and 55.1 nm, respectively and significant higher entrapment efficiency. Encapsulation of quercetin (QC) in LNC enabled us to increase its apparent aqueous solubility by a factor of 100. And in view of calculations and results, it seems most probable that QC is arranged at this LNC interface between the oil phase and the hydrophilic polyethylene glycol moieties of the surfactant. In addition, colloidal suspensions proved to be stable in term of encapsulation for at least 10 weeks and QC was not oxidised. With simple chemical modification of (-)-epigallocatechin-3-gallate or (-)-EGCG, it was possible to reach very high encapsulation rates (95%). Thus we obtained stable colloidal suspensions of (-)-EGCG in water over 4 weeks while free (-)-EGCG solubilised in water exhibited 100% degradation within 4 h. The initial problems (solubility and stability) of these flavonoids were resolved thanks to drug-loaded LNC. (C) 2009 Published by Elsevier B.V.
引用
收藏
页码:270 / 277
页数:8
相关论文
共 26 条
[1]
Cornard JP, 1997, BIOSPECTROSCOPY, V3, P183, DOI 10.1002/(SICI)1520-6343(1997)3:3<183::AID-BSPY2>3.3.CO
[2]
2-6
[3]
Drummond DC, 1999, PHARMACOL REV, V51, P691
[4]
THE EFFECT OF PARENTERALLY ADMINISTERED CYCLODEXTRINS ON CHOLESTEROL LEVELS IN THE RAT [J].
FRIJLINK, HW ;
EISSENS, AC ;
HEFTING, NR ;
POELSTRA, K ;
LERK, CF ;
MEIJER, DKF .
PHARMACEUTICAL RESEARCH, 1991, 8 (01) :9-16
[5]
Advances in flavonoid research since 1992 [J].
Harborne, JB ;
Williams, CA .
PHYTOCHEMISTRY, 2000, 55 (06) :481-504
[6]
The influence of lipid nanocapsule composition on their size distribution [J].
Heurtault, B ;
Saulnier, P ;
Pech, B ;
Venier-Julienne, MC ;
Proust, JE ;
Phan-Tan-Luu, R ;
Benoît, JP .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 18 (01) :55-61
[7]
A novel phase inversion-based process for the preparation of lipid nanocarriers [J].
Heurtault, B ;
Saulnier, P ;
Pech, B ;
Proust, JE ;
Benoit, JP .
PHARMACEUTICAL RESEARCH, 2002, 19 (06) :875-880
[8]
Kadykova E.L., 1993, KOKSNES KIMIJA, V1-3, P107
[9]
Synthesis of (-)-[4-3H]epigallocatechin gallate and its metabolic fate in rats after intravenous administration [J].
Kohri, T ;
Nanjo, F ;
Suziki, M ;
Seto, R ;
Matsumoto, N ;
Yamakawa, M ;
Hojo, H ;
Hara, Y ;
Desai, D ;
Amin, S ;
Conaway, CC ;
Chung, FL .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2001, 49 (02) :1042-1048
[10]
In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel [J].
Lacoeuille, F. ;
Hindre, F. ;
Moal, F. ;
Roux, J. ;
Passirani, C. ;
Couturier, O. ;
Cales, P. ;
Le Jeune, J. J. ;
Lamprecht, A. ;
Benoit, J. P. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 344 (1-2) :143-149